Regeneron Pharmaceuticals: At 14-Months Median Follow-up in Trial, 50% of Patients Achieved a Complete Response or Better, a 71% Overall Response Rate
再生元製藥公司:在14個月的中位隨訪期內,有50%的患者達到了完全緩解或更好的療效,總體反應率爲71%。
Regeneron Pharmaceuticals: At 14-Months Median Follow-up in Trial, 50% of Patients Achieved a Complete Response or Better, a 71% Overall Response Rate
再生元製藥公司:在14個月的中位隨訪期內,有50%的患者達到了完全緩解或更好的療效,總體反應率爲71%。
譯文內容由第三人軟體翻譯。